F17.293
Nicotine dependence, other tobacco product, with withdrawal
Clinical Classification Guidelines
Medical Intelligence & Overview
Nicotine dependence on products other than cigarettes, such as cigars, smokeless tobacco, or vaping products, can lead to significant health challenges. When a person relies heavily on these products, their body becomes accustomed to nicotine, resulting in withdrawal symptoms if usage stops. This condition is classified under ICD-10 code F17.293, indicating dependence on other tobacco products with withdrawal symptoms. Understanding this condition can help individuals recognize the signs and seek appropriate support to manage their dependence and withdrawal effectively.
Causes & Symptoms
Clinical Causes: Regular use of non-cigarette tobacco products, including cigars, pipe tobacco, smokeless tobacco (chewing tobacco, snuff), or nicotine-containing vaping products. Repeated exposure to nicotine, leading to changes in brain chemistry that create dependence. Genetic predisposition, increasing susceptibility to nicotine addiction. Environmental factors, such as peer influence, social settings, and advertising promoting tobacco use. Psychological factors, including stress, anxiety, or habitual routines that are associated with tobacco use.
Key Symptoms: Cravings for tobacco products Irritability or frustration Anxiety or restlessness Difficulty concentrating without tobacco use Increased appetite or weight gain Headache, dizziness, or difficulty sleeping Mood swings and feelings of depression
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a healthcare professional evaluating a person's history of tobacco product use, dependence symptoms, and withdrawal experiences. Diagnostic assessments may include structured interviews, questionnaires, and physical examinations to confirm dependence and identify withdrawal symptoms. No specific laboratory test can diagnose nicotine dependence, but biological markers like cotinine levels can support assessments of recent tobacco use.
Treatment Protocols: Managing nicotine dependence involves several strategies aimed at reducing withdrawal symptoms and preventing relapse. Common approaches include: - **Behavioral therapies**: counseling, support groups, and cognitive-behavioral therapy to address behavioral patterns linked with tobacco use. - **Pharmacological treatments**: nicotine replacement therapies (patches, gum, lozenges), non-nicotine medications like bupropion or varenicline to reduce cravings and withdrawal symptoms. - **Lifestyle modifications**: incorporating physical activity, stress management techniques, and healthy routines to support cessation. - **Educational support**: increasing awareness about the risks of tobacco use and benefits of quitting. It's crucial for individuals seeking to quit nicotine products to consult healthcare providers for tailored treatment plans and support systems, as complete cessation can significantly improve overall health.
Clinical Advice & FAQs
Billing Guidance
Is F17.293 a billable ICD-10 code?
Yes, F17.293 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F17.293?
Clinical documentation must specify the nature of Nicotine dependence, other tobacco product, with withdrawal and any associated comorbidities for accurate reporting.
Cite this Clinical Reference